ADVM Earnings
Adverum Biotechnologies Inc
$
2.290
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Adverum Biotechnologies Inc(ADVM) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Adverum Biotechnologies Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q1 | 2025-05-14 | After Hours | -1.92 | -2.25 | -17.19 | 950.00K | 0.00 | -100.00 | -0.49 | +21.36 |
| - | 2024-08-08 | After Hours | -1.27 | - | - | 530.00K | - | - | -5.20 | -5.64 |
| FY2024Q1 | 2024-05-09 | - | -1.28 | -1.50 | -17.19 | 72.86K | - | - | -2.04 | -10.81 |
| FY2023Q4 | 2024-03-18 | - | -0.28 | -0.23 | +17.86 | - | - | - | +4.12 | -5.53 |
| FY2023Q3 | 2023-11-09 | - | -0.30 | -0.33 | -10.00 | - | - | - | -1.09 | -4.35 |
| FY2023Q2 | 2023-08-10 | - | -0.32 | -0.31 | +3.12 | - | - | - | -1.08 | -7.57 |
| - | 2023-05-11 | - | -0.30 | -0.29 | +3.33 | - | - | - | -1.06 | -6.83 |
| - | 2023-03-30 | - | -0.32 | -0.33 | -3.13 | - | - | - | -4.13 | -3.86 |
| - | 2022-11-10 | - | -0.32 | -0.40 | -25.00 | - | - | - | +7.65 | -5.74 |
| - | 2022-08-11 | - | -0.38 | -0.44 | -15.79 | - | - | - | -1.95 | -12.34 |
ADVM Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Adverum Biotechnologies Inc reported performance for FY2025Q1, announced on 2025-05-14. The company achieved an EPS of -2.25, compared to analyst estimates of -1.92 by -17.19% . Revenue for the quarter reached 0.00 compared to expectations of 950.00K by -100.00% .
The stock price reacted with a -0.49% one-day change and a 21.36% five-day change following the earnings release. These movements reflect market reaction in Adverum Biotechnologies Inc growth trajectory and strategic initiatives.
ADVM Earnings Forecast
Looking ahead, Adverum Biotechnologies Inc(ADVM) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 7894.9%, while EPS estimates have been Revise Upward by 50%. For the upcoming , revenue estimates have been adjusted Go Down by -15.50% . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Adverum Biotechnologies Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between ADVM's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
+7894.9%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Upward
+50%
In Past 3 Month
Stock Price
Go Down
-15.50%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:12.66M
--
EPS Estimate-Annual FY 2025:0
—
Stock Price2.29
ADVM Revenue and EPS Performance: A Historical Perspective
Adverum Biotechnologies Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q1 (2025-05-14,After Hours):
EPS: -2.25 (Actual) vs.-1.92 (Estimate) (-17.19%)
Revenue: 0.00 (Actual) vs. 950.00K (Estimate) (-100.00%)
Price Reaction: -0.49%(1-Day), 21.36%(5-Day)
(2024-08-08,After Hours):
EPS: (Actual) vs.-1.27 (Estimate) (%)
Revenue: 0.00 (Actual) vs. 530.00K (Estimate) (%)
Price Reaction: -5.20%(1-Day), -5.64%(5-Day)
FY2024Q1 (2024-05-09,):
EPS: -1.50 (Actual) vs.-1.28 (Estimate) (-17.19%)
Revenue: 0.00 (Actual) vs. 72.86K (Estimate) (%)
Price Reaction: -2.04%(1-Day), -10.81%(5-Day)
Earnings Reaction
The chart below shows how ADVM performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ADVM sees a +13.81% change in stock price 10 days leading up to the earnings, and a -3.91% change 10 days following the report. On the earnings day itself, the stock moves by -0.41%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in MAR/2025, the stock changed -0.49% on the day following the earnings release and then changed by 9.71% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
No Data
People Also Watch
INVE
Identiv Inc
3.580
USD
-0.56%
COYA
Coya Therapeutics Inc
6.080
USD
-0.33%
GRWG
GrowGeneration Corp
1.050
USD
+2.94%
TRX
TRX Gold Corp
0.370
USD
+1.65%
MNOV
MediciNova Inc
1.350
USD
-1.46%
DTSQ
DT Cloud Star Acquisition Corp
0
USD
+0.10%
SIFY
Sify Technologies Ltd
8.200
USD
+3.67%
OPRX
OptimizeRx Corp
17.300
USD
+34.74%
LTBR
Lightbridge Corp
13.770
USD
-2.13%
FAQ
What were the key highlights of ADVM’s latest earnings report for FY2025Q1?
ADVM reported its FY2025Q1 earnings on 2025-05-14, showcasing a revenue of 0.00 against an estimate of 950.00K, resulting in a -100% surprise. The EPS was -2.25, surpassing the expected -1.92 by -17.19% . The stock experienced a -0.49% price change on the earnings day and a 21.36% change over the next five days, reflecting market reactions to the results.
How did ADVM’s stock price react after the FY2025Q1 earnings release?
What are the revenue and EPS estimates for ADVM for undefined?
How does ADVM’s stock price correlate with earnings forecast revisions?
What should investors expect from ADVM’s next earnings report?